- Home
- NRIX vs TPB Comparison
NRIX vs TPB Comparison
Compare NRIX & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | TPB |
|---|---|---|
| Founded | 2009 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Tobacco |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NRIX | TPB |
|---|---|---|
| Price | $22.10 | $87.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $30.50 | ★ $115.00 |
| AVG Volume (30 Days) | ★ 2.9M | 436.7K |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | ★ 45.33 |
| EPS | N/A | ★ 3.11 |
| Revenue | $76,987,000.00 | ★ $463,062,000.00 |
| Revenue This Year | N/A | $13.68 |
| Revenue Next Year | $48.05 | $11.32 |
| P/E Ratio | ★ N/A | $27.02 |
| Revenue Growth | ★ 99.31 | 28.39 |
| 52 Week Low | $8.20 | $65.80 |
| 52 Week High | $23.09 | $146.90 |
Technical Indicators
Market Signals| Indicator | NRIX | TPB |
|---|---|---|
| Relative Strength Index (RSI) | 76.33 | 55.13 |
| Support Level | $14.86 | $86.79 |
| Resistance Level | $22.50 | $93.44 |
| Average True Range (ATR) | 1.61 | 4.18 |
| MACD | 0.61 | 0.46 |
| Stochastic Oscillator | 80.60 | 95.58 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.